Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Jameson

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Journal of Medical Radiation Sciences|August 3, 2020
Deforming to Best Practice: Key considerations for deformable image registration in radiotherapyJeffrey Barber, Johnson Yuen, Michael Jameson, et al.
International Journal of Radiation Oncology, Biology, Physics|January 20, 2026
The KIM real-time prostate cancer IGRT technology journey: From clinical trials to your clinicPaul J Keall, Jeremy Booth, Thomas Eade, et al.
The New Zealand Medical Journal|December 12, 2024
Process of development of decentralised clinical trial methodology for cancer clinical trials in Aotearoa New ZealandNicola J Lawrence, Bobbi B Laing, Joseph Tyro, et al.
Frontiers in Oncology|September 27, 2019
A Multi-center Prospective Study for Implementation of an MRI-Only Prostate Treatment Planning WorkflowPeter Greer, Jarad Martin, Mark Sidhom, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2021
Intralesional SD-101 in Combination with Pembrolizumab in Anti-PD-1 Treatment-Naïve Head and Neck Squamous Cell Carcinoma: Results from a Multicenter, Phase II TrialEzra E W Cohen, Lisle Nabell, Deborah J Wong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 2020
Phase I, Open-Label, Dose-Escalation/Dose-Expansion Study of Lifirafenib (BGB-283), an RAF Family Kinase Inhibitor, in Patients With Solid TumorsJayesh Desai, Hui Gan, Catherine Barrow, et al.
Journal for Immunotherapy of Cancer|June 17, 2020
Phase IA/IB study of single-agent tislelizumab, an investigational anti-PD-1 antibody, in solid tumorsJayesh Desai, Sanjeev Deva, Jong Seok Lee, et al.
Medical Physics|July 15, 2025
TrackRAD2025 challenge dataset: real-time tumor tracking for MRI-guided radiotherapyYiling Wang, Elia Lombardo, Adrian Thummerer, et al.
Medical Image Analysis|May 26, 2026
MRIgRT real-time target tracking: TrackRAD2025 challenge reportTom Julius Blöcker, Pia A W Görts, Yiling Wang, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Journal of Medical Radiation Sciences|August 3, 2020
Deforming to Best Practice: Key considerations for deformable image registration in radiotherapyJeffrey Barber, Johnson Yuen, Michael Jameson, et al.
International Journal of Radiation Oncology, Biology, Physics|January 20, 2026
The KIM real-time prostate cancer IGRT technology journey: From clinical trials to your clinicPaul J Keall, Jeremy Booth, Thomas Eade, et al.
The New Zealand Medical Journal|December 12, 2024
Process of development of decentralised clinical trial methodology for cancer clinical trials in Aotearoa New ZealandNicola J Lawrence, Bobbi B Laing, Joseph Tyro, et al.
Frontiers in Oncology|September 27, 2019
A Multi-center Prospective Study for Implementation of an MRI-Only Prostate Treatment Planning WorkflowPeter Greer, Jarad Martin, Mark Sidhom, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2021
Intralesional SD-101 in Combination with Pembrolizumab in Anti-PD-1 Treatment-Naïve Head and Neck Squamous Cell Carcinoma: Results from a Multicenter, Phase II TrialEzra E W Cohen, Lisle Nabell, Deborah J Wong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 2020
Phase I, Open-Label, Dose-Escalation/Dose-Expansion Study of Lifirafenib (BGB-283), an RAF Family Kinase Inhibitor, in Patients With Solid TumorsJayesh Desai, Hui Gan, Catherine Barrow, et al.
Journal for Immunotherapy of Cancer|June 17, 2020
Phase IA/IB study of single-agent tislelizumab, an investigational anti-PD-1 antibody, in solid tumorsJayesh Desai, Sanjeev Deva, Jong Seok Lee, et al.
Medical Physics|July 15, 2025
TrackRAD2025 challenge dataset: real-time tumor tracking for MRI-guided radiotherapyYiling Wang, Elia Lombardo, Adrian Thummerer, et al.
Medical Image Analysis|May 26, 2026
MRIgRT real-time target tracking: TrackRAD2025 challenge reportTom Julius Blöcker, Pia A W Görts, Yiling Wang, et al.
Pageof 4